These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 552225)

  • 1. Biological standardization of potency testing of diphtheria-tetanus-pertussis vaccines.
    Csizér Z; Zsidai J
    Ann Immunol Hung; 1979; 19():53-74. PubMed ID: 552225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An antibody induction method in mice for the potency assays of diphtheria and tetanus components in combined vaccines.
    Maheshwari SC; Sharma SB; Kumar A; Sokhey J
    J Commun Dis; 1998 Sep; 30(3):139-46. PubMed ID: 10093418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Report of an informal meeting about alternative methods for the potency control of the diphtheria and tetanus components in vaccines.
    Kreeftenberg JG
    Dev Biol Stand; 1986; 65():261-6. PubMed ID: 3493932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the minimal number of animals required to achieve assurance of satisfactory potency in diphtheria and tetanus vaccines.
    Knight PA; Roberts PA
    Dev Biol Stand; 1986; 65():245-53. PubMed ID: 3493931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potency control of tetanus and diphtheria toxoids, adsorbed, produced in Bulgaria.
    Vrancheva S; Vulchev V; Bachev S
    Prog Immunobiol Stand; 1970; 4():548-52. PubMed ID: 5482199
    [No Abstract]   [Full Text] [Related]  

  • 7. Collaborative study: Standardization of Japanese reference diphtheria and tetanus toxoids, (adsorbed, lot 2), for potency determination of diphtheria-tetanus- acellular pertussis combined vaccine.
    Iwaki M; Komiya T; Fukuda T; Arakawa Y; Takahashi M
    Jpn J Infect Dis; 2003 Aug; 56(4):183-5. PubMed ID: 14583650
    [No Abstract]   [Full Text] [Related]  

  • 8. Quadruple vaccines containing pertussis and poliomyelitis vaccines.
    Anderson GR; Gottshall RY; Nelsom E; Angela F
    Health Lab Sci; 1978 Jul; 15(3):138-43. PubMed ID: 568123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory testing of combined diphtheria-tetanus-pertussis-typhoid vaccines.
    Csizér Z; Joó I; Réthy L; Juhász VP
    Prog Immunobiol Stand; 1971; 5():394-8. PubMed ID: 4660543
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combined pertussis-tetanus-diphtheria-polio vaccine. Laboratory tests].
    Schiller B; Grodzicka WB; Rudnicka W
    Med Dosw Mikrobiol; 1973; 25(3):231-8. PubMed ID: 4760226
    [No Abstract]   [Full Text] [Related]  

  • 11. [The determination of the protective potency of the diphtheria component in combined vaccines by the indirect hemagglutination (IHA) method].
    Unver SD; Ozcengiz E
    Mikrobiyol Bul; 1990 Oct; 24(4):327-35. PubMed ID: 2287290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a mouse model to estimate the potency of the diphtheria toxoid component of diphtheria-tetanus and diphtheria-tetanus-pertussis vaccines.
    Maheshwari SC; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1988 Jul; 16(3):139-46. PubMed ID: 3170614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reduction of animal usage by the application of indirect haemagglutination in the potency testing of diphtheria toxoid in combined vaccines.
    Maheshwari SC; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1988 Jan; 16(1):9-14. PubMed ID: 3258309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in animal usage for potency testing of diphtheria and tetanus toxoids.
    Stainer DW; Jakus CM; Sparkes JD
    Dev Biol Stand; 1986; 65():241-4. PubMed ID: 3556773
    [No Abstract]   [Full Text] [Related]  

  • 16. The results of study of pertussis component of DPT vaccine produced in USSR and some other countries.
    Zakharova MS; Malivanova OM; Sokolovskaya AD; Shavrova EN; Kapustik LA
    J Hyg Epidemiol Microbiol Immunol; 1981; 25(4):439-48. PubMed ID: 7320507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental study on estimating the immunogenic potency of diphtheria and/or tetanus toxoids in monovaccines and associated vaccines.
    Durbacă S; Andronescu C; Diaconescu A
    Roum Arch Microbiol Immunol; 1996; 55(2):119-31. PubMed ID: 9253238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of in vivo and in vitro methods for determining unitage of diphtheria antitoxin in adsorbed diphtheria-tetanus (DT) and diphtheria-tetanus-pertussis (DTP) vaccines.
    Shinde YP; Jadhav SS
    Dev Biol Stand; 1996; 86():245-60. PubMed ID: 8785954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of the Lf content of diphtheria toxoid as a guide to its immunogenic value in DPT vaccine.
    Habbu MK; Poonawalla CS; Parvatikar MS; Jadhav SS
    Indian Pediatr; 1987 Feb; 24(2):141-4. PubMed ID: 3499394
    [No Abstract]   [Full Text] [Related]  

  • 20. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines-part 1.
    Winsnes R; Sesardic D; Daas A; Behr-Gross ME
    Pharmeuropa Bio; 2004 Jan; 2003(2):35-68. PubMed ID: 14960262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.